Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study

<h4>Background</h4> Many studies have assessed the association between anemia and mortality in hemodialysis but few compared patients with and without diabetes. Our study aims to investigate the impact of hemoglobin and iron parameters on mortality in hemodialysis patients with or withou...

Full description

Bibliographic Details
Main Authors: Jihane Asmar, Dania Chelala, Razane El Hajj Chehade, Hiba Azar, Serge Finianos, Mabel Aoun
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888689/?tool=EBI
_version_ 1811173555811909632
author Jihane Asmar
Dania Chelala
Razane El Hajj Chehade
Hiba Azar
Serge Finianos
Mabel Aoun
author_facet Jihane Asmar
Dania Chelala
Razane El Hajj Chehade
Hiba Azar
Serge Finianos
Mabel Aoun
author_sort Jihane Asmar
collection DOAJ
description <h4>Background</h4> Many studies have assessed the association between anemia and mortality in hemodialysis but few compared patients with and without diabetes. Our study aims to investigate the impact of hemoglobin and iron parameters on mortality in hemodialysis patients with or without diabetes. <h4>Methods</h4> This is a two-center retrospective study that included all adult patients who started hemodialysis between February 2012 and February 2020, followed until January 2021. Averages of hemoglobin, ferritin and transferrin saturation of entire follow-up were recorded. Kaplan Meier survival, log rank test and cox regression analyses were performed to assess the association between anemia biomarkers and mortality. <h4>Results</h4> A total of 214 patients were included. Mean age was 67.98 ±12.41 years, mean hemoglobin was 10.92 ±0.75 g/dL, mean ferritin was 504.43 ± 221.42 ng/mL and mean transferrin saturation was 26.23 ±7.77%. Log rank test showed an association between hemoglobin ≥11 g/dL and better survival in patients without diabetes (P = 0.028). Based on cox regression analysis, hemoglobin was associated with all-cause mortality in all patients (HR = 0.66; CI:0.49,0.89; P = 0.007). When comparing patients with and without diabetes, this association remained significant only in patients without diabetes (HR = 0.53; CI:0.37,0.77; P<0.001). Based on different multivariate models, hemoglobin, ferritin and age were independent factors associated with mortality in patients without diabetes. <h4>Conclusions</h4> This study showed that hemoglobin ≥11 g/dL is associated with better survival in hemodialysis patients without diabetes but not in those with diabetes. These differences need to be further explored in other countries and settings. An individualization of the hemoglobin target level might be necessary to improve patients’ outcomes.
first_indexed 2024-04-10T17:48:55Z
format Article
id doaj.art-a346ab90b6234227a972506f06b3d2c0
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-10T17:48:55Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-a346ab90b6234227a972506f06b3d2c02023-02-02T22:58:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01181Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up studyJihane AsmarDania ChelalaRazane El Hajj ChehadeHiba AzarSerge FinianosMabel Aoun<h4>Background</h4> Many studies have assessed the association between anemia and mortality in hemodialysis but few compared patients with and without diabetes. Our study aims to investigate the impact of hemoglobin and iron parameters on mortality in hemodialysis patients with or without diabetes. <h4>Methods</h4> This is a two-center retrospective study that included all adult patients who started hemodialysis between February 2012 and February 2020, followed until January 2021. Averages of hemoglobin, ferritin and transferrin saturation of entire follow-up were recorded. Kaplan Meier survival, log rank test and cox regression analyses were performed to assess the association between anemia biomarkers and mortality. <h4>Results</h4> A total of 214 patients were included. Mean age was 67.98 ±12.41 years, mean hemoglobin was 10.92 ±0.75 g/dL, mean ferritin was 504.43 ± 221.42 ng/mL and mean transferrin saturation was 26.23 ±7.77%. Log rank test showed an association between hemoglobin ≥11 g/dL and better survival in patients without diabetes (P = 0.028). Based on cox regression analysis, hemoglobin was associated with all-cause mortality in all patients (HR = 0.66; CI:0.49,0.89; P = 0.007). When comparing patients with and without diabetes, this association remained significant only in patients without diabetes (HR = 0.53; CI:0.37,0.77; P<0.001). Based on different multivariate models, hemoglobin, ferritin and age were independent factors associated with mortality in patients without diabetes. <h4>Conclusions</h4> This study showed that hemoglobin ≥11 g/dL is associated with better survival in hemodialysis patients without diabetes but not in those with diabetes. These differences need to be further explored in other countries and settings. An individualization of the hemoglobin target level might be necessary to improve patients’ outcomes.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888689/?tool=EBI
spellingShingle Jihane Asmar
Dania Chelala
Razane El Hajj Chehade
Hiba Azar
Serge Finianos
Mabel Aoun
Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study
PLoS ONE
title Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study
title_full Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study
title_fullStr Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study
title_full_unstemmed Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study
title_short Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study
title_sort anemia biomarkers and mortality in hemodialysis patients with or without diabetes a 10 year follow up study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888689/?tool=EBI
work_keys_str_mv AT jihaneasmar anemiabiomarkersandmortalityinhemodialysispatientswithorwithoutdiabetesa10yearfollowupstudy
AT daniachelala anemiabiomarkersandmortalityinhemodialysispatientswithorwithoutdiabetesa10yearfollowupstudy
AT razaneelhajjchehade anemiabiomarkersandmortalityinhemodialysispatientswithorwithoutdiabetesa10yearfollowupstudy
AT hibaazar anemiabiomarkersandmortalityinhemodialysispatientswithorwithoutdiabetesa10yearfollowupstudy
AT sergefinianos anemiabiomarkersandmortalityinhemodialysispatientswithorwithoutdiabetesa10yearfollowupstudy
AT mabelaoun anemiabiomarkersandmortalityinhemodialysispatientswithorwithoutdiabetesa10yearfollowupstudy